Amrutanjan Health Care Limited

NSEI:AMRUTANJAN Voorraadrapport

Marktkapitalisatie: ₹20.6b

Amrutanjan Health Care Inkomsten in het verleden

Verleden criteriumcontroles 4/6

Amrutanjan Health Care is de winst gegroeid met een gemiddeld jaarlijks percentage van 2.4%, terwijl de Pharmaceuticals industrie de winst jaarlijks groeide met 13.4%. De inkomsten zijn gegroeid met een gemiddelde snelheid van 9.2% per jaar. Het rendement op eigen vermogen van Amrutanjan Health Care is 16%, en het heeft een nettomarge van 10.9%.

Belangrijke informatie

2.4%

Groei van de winst

2.5%

Groei van de winst per aandeel

Pharmaceuticals Groei van de industrie17.5%
Inkomstengroei9.2%
Rendement op eigen vermogen16.0%
Nettomarge10.9%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

May 31
We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

Recent updates

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Nov 19
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 17
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

May 31
We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

May 03
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Feb 12
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Sep 02
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Aug 05
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Feb 17
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Nov 08
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Aug 18
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 30
Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Apr 08
Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Mar 11
Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Feb 24
Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Feb 14
Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 12
Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Jan 30
Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Jan 17
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

Jan 04
Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

Dec 22
What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

Dec 09
How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Nov 26
If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Nov 14
Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Oct 28
Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

Oct 10
Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

Sep 22
I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

Sep 01
What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For

Aug 11
With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For

Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?

Jul 29
Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?

Opbrengsten en kosten

Hoe Amrutanjan Health Care geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.


Inkomsten en omzetgeschiedenis

NSEI:AMRUTANJAN Opbrengsten, kosten en inkomsten (INR Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 244,3784755370
30 Jun 244,2714261,0480
31 Mar 244,2144504840
31 Dec 233,9464403980
30 Sep 233,7533734610
30 Jun 233,8654329730
31 Mar 233,7983984930
31 Dec 223,8604185000
30 Sep 223,9905174940
30 Jun 223,9865881,0370
31 Mar 224,0596725050
31 Dec 213,9356271,2110
30 Sep 213,8296311,1590
30 Jun 213,6446689660
31 Mar 213,3306124970
31 Dec 202,9845897630
30 Sep 202,8114747770
30 Jun 202,6353228090
31 Mar 202,6172518340
31 Dec 192,8763148330
30 Sep 192,7512748040
30 Jun 192,6212577500
31 Mar 192,5352507560
31 Dec 182,4061587850
30 Sep 182,3351687620
30 Jun 182,2882017100
31 Mar 182,2032006710
31 Dec 172,2471657220
31 Mar 172,2402117100
31 Mar 161,8672065050
31 Mar 151,6661494680
31 Mar 141,4171245081

Kwaliteitswinsten: AMRUTANJAN heeft een hoog niveau van non-cash earnings.

Groeiende winstmarge: De huidige netto winstmarges (10.9%) AMRUTANJAN } zijn hoger dan vorig jaar (9.9%).


Analyse vrije kasstroom versus winst


Analyse van de winstgroei in het verleden

Winsttrend: De winst van AMRUTANJAN is de afgelopen 5 jaar met 2.4% per jaar gegroeid.

Versnelling van de groei: De winstgroei van AMRUTANJAN over het afgelopen jaar ( 27.5% ) overtreft het 5-jarig gemiddelde ( 2.4% per jaar).

Winst versus industrie: De winstgroei AMRUTANJAN over het afgelopen jaar ( 27.5% ) overtrof de Pharmaceuticals -sector 20%.


Rendement op eigen vermogen

Hoge ROE: Het Rendement op eigen vermogen ( 16% ) van AMRUTANJAN wordt als laag beschouwd.


Rendement op activa


Rendement op geïnvesteerd vermogen


Ontdek sterk presterende bedrijven uit het verleden